Hartley Dylan

Hartley Dylan is listed in filings as Chief Scientific Officer at OnKure Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 3, 2026, including 3 public disclosures. Recent filings connect the profile to OnKure Therapeutics, Inc. (OKUR). The current snapshot covers public activity from Oct 8, 2024 to Apr 3, 2026. Reported amounts are shown as $447.7K to $2.5M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.